The partnership leverages the Hesperos organ-on-a-chip platform in the preclinical development of Psilera’s lead compound ...

Pharmaceutical Technology serves as the connection to bio manufacturing and development, featuring regulatory updates and ...

Most of the company’s new additions, if not already online, will be scheduled for commissioning, validation, or qualification ...

Smart technologies, such as digital and laser printing, incorporated into manufacturing equipment are helping manufacturers ...

The company describes the compact system as ergonomically designed, providing precision dosing and production floor ...

ICH Q6B provides expectations and a clear framework for the structural characterization of biopharmaceutical products.

ICH Q6B provides expectations and a clear framework for the structural characterization of biopharmaceutical products.

How Techceuticals, PharmParts, and smart auction strategies are ushering in a new era of efficiency and innovation for CDMOs ...

Trends in certain forms of drug delivery, as well as the emergence of artificial intelligence, are playing roles in evolving ...

As a result of the decision, Shilpa will not be eligible to receive FDA approval for its lenvatinib mesylate generic until February 2036.

The new lab will be used to develop and scale innovations for the production of medicines and to help secure the supply chain ...